ACR Lupus Nephritis Guidelines: What Clinicians Need to Know with Sam Good, MD

In honor of World Lupus Day, Dr. Sam Good reviews the ACR Guidelines for the screening, treatment, and management of lupus nephritis, released in Arthritis & Rheumatology. This video focuses on what’s new in treatment, including the shift toward triple therapy, updated steroid recommendations, and new biologic options. 🔍 Highlights include 🧪 Triple Therapy: Steroids + mycophenolate + belimumab or calcineurin inhibitor (CNI) 💊 Lower-dose steroid strategies - max 40 mg prednisone/day 🧬 Use of belimumab in patients with low GFR or extra-renal manifestations 💡 Role of CNIs in proteinuria more than 3g/day with preserved kidney function 💉 What to do when triple therapy fails: Anti-CD20 agents, reassessing adherence, and repeat biopsy 📈 Class V lupus nephritis updates: Clearer recommendations for when to add CNIs Perfect for rheumatologists, nephrologists, and internal medicine clinicians managing lupus and kidney involvement. 👉 Watch the full course now at: https://scholarsinmedicine.com/specia... #LupusNephritis #LupusTreatment #ACRGuidelines #Rheumatology #WorldLupusDay #ScholarsInMedicine #MedicalEducation #TripleTherapy #Belimumab #CalcineurinInhibitor